Search

everythinglearnresearchcommunity

for

Search:↓

Prompt treatment of inflammatory tinea capitis (kerion) is crucial to prevent scarring and hair loss.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Recognizing specific features of African-American hair can help diagnose hair loss conditions.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

A rare genetic skin condition usually affecting males was found in a 9-year-old girl.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Two mouse mutations cause similar hair loss despite different skin changes.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Apremilast shows promise for several skin conditions but needs more research.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.